pseudohypoaldosteronism type 2
ORPHA: 757
Overview
Pseudohypoaldosteronism type 2 (PHA2) is a rare inherited form of hypertension characterized by hyperkalemia, hyperchloremic metabolic acidosis, normal or elevated aldosterone, low renin, and normal renal function
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with pseudohypoaldosteronism type 2, sourced from HPO and Orphanet clinical annotations.
Abnormality of the dentitionAbnormal dental enamel morphologyHypertensionMuscle weaknessGrowth delayNausea and vomitingHyperkalemiaPeriodic paralysisShort stature
Classification & Codes
Orphanet Code
ORPHA:757pseudohypoaldosteronism type 2
| Orphanet | ORPHA:757 |
| Treatments | 0 drug(s) |
| Symptoms on record | 9 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO